10 News & Press Releases found
SeqOne S.A.S. News
-
SeqOne Genomics appoints Hervé Pouzoullic as Chief Commercial Officer
SeqOne Genomics, provider of nextgeneration genomic analysis solutions for personalized medicine, announces the appointment of Hervé Pouzoullic as Chief Commercial Officer (CCO). He will lead the commercial development of the company to ...
-
SeqOne Genomics and the French Thrombotic MicroAngiopathies National reference center (CNR-MAT) pioneer the use of Oxford Nanopore sequencing technology to improve patient outcomes in kidney disease while reducing turnaround times
SeqOne today announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies (CNR-MAT), aimed at improving the diagnosis ...
-
Michael Blum joins SeqOne Genomics to head the company’s Research and Development
SeqOne Genomics, today announced that Michael Blum, Ph.D. is joining the company to lead its research and development department. He is tasked with driving SeqOne’s R&D strategy notably in the area of rare diseases and oncology through the ...
-
SeqOne Genomics announces Portuguese distribution partnership
SeqOne Genomics, provider of next-generation genomic analysis solutions for personalized medicine is proud to announce a new strategic partnership with ILC Instrumentos de Laboratório Científicos to facilitate access to its ...
-
SeqOne Genomics selected as genomic analysis solution for CELIA (Comprehensive Genomic profiling impact) project, in collaboration with Illumina
The project aims to compare the clinical utility of broad-spectrum genomic profiling in the treatment of late-stage cancer patients with more traditional approaches that analyze a limited set of genes and thus influence the precision medicine ...
-
SeqOne Genomics closes €20M series A to accelerate the deployment of its genomic medicine platform
The round, led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors, Elaia and IRDI Capital Investissement, will enable SeqOne Genomics to accelerate its international sales and the development of new ...
-
SeqOne expands its commercial presence in Middle Eastern markets
SeqOne Genomics, a leader in the field of next generation genomics analysis, announces today a distribution partnership with Global Diagnostic Solutions Ltd (GDS) to commercialize SeqOne’s revolutionary genomics analysis software platform in ...
-
A French start-up harnesses the power of the latest generation genomic sequencers to dramatically increase COVID 19 testing capacity
SeqOne Genomics, a start-up specialized in genomic analysis software, is partnering with leading medical testing labs to develop an approach that delivers up to 100 times more COVID 19 tests per machine thanks to NGS sequencers. Epidemiological ...
-
Eurofins Biomnis and Seqone Partner to Improve Clinical Access to Whole Exome Testing
Eighty percent of rare diseases are genetic in origin and result from a small number of genetic mutations. Identifying these variations is essential in diagnosing the diseases and can dramatically improve patient care. Making Whole Exome sequencing ...
-
SeqOne wins prestigious iLab grant to improve genomics analysis software in healthcare
SeqOne a French start-up in the genomic medicine market is proud to announce that it has been awarded an i-Lab grant by the Ministry of Education and Technology. i-Lab is a national competition open to all French start-ups designed to identify ...